0000939767-21-000105.txt : 20211123
0000939767-21-000105.hdr.sgml : 20211123
20211123201155
ACCESSION NUMBER: 0000939767-21-000105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211119
FILED AS OF DATE: 20211123
DATE AS OF CHANGE: 20211123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FELDBAUM CARL B
CENTRAL INDEX KEY: 0001326377
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 211440748
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY, PO BOX 511
CITY: SOUTH SAN FRISCISCO
STATE: CA
ZIP: 94083-0511
FORMER NAME:
FORMER CONFORMED NAME: Feldbaum Carl B
DATE OF NAME CHANGE: 20050506
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_163771629639082.xml
FORM 4
X0306
4
2021-11-19
0
0000939767
EXELIXIS, INC.
EXEL
0001326377
FELDBAUM CARL B
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
1
0
0
0
Common Stock
2021-11-19
4
M
0
20000
3.13
A
28521
D
Common Stock
2021-11-19
4
S
0
20000
17.62
D
8521
D
Option (right to buy)
3.13
2021-11-19
4
M
0
20000
0
D
2015-05-28
2022-05-27
Common Stock
20000.0
20000
D
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.57 to $17.68. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2021-11-23